Acupuncture for Pain Control in Patients With Inoperable Pancreatic Cancer
Electroacupuncture Analgesia in Patients With Inoperable Pancreatic Cancer: A Randomized, Sham-controlled Study
Sponsor: Chinese University of Hong Kong
Terminated
Expertise resigned
Other terminated trials from Chinese University of Hong Kong
This NA trial investigates Cancer of Pancreas and Pain and is currently terminated or withdrawn. Chinese University of Hong Kong leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Aug 2020 — Jan 2021 [monthly]
Terminated NA
Status: Recruiting → Terminated · Phase: PHASE3 → NA
-
Aug 2019 — Aug 2020 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
▶ Show 3 earlier versions
-
Jun 2018 — Aug 2019 [monthly]
Not Yet Recruiting PHASE3
-
Feb 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE3
First recorded
Mar 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chinese University of Hong Kong
For direct contact, visit the study record on ClinicalTrials.gov .